Skip to main content
Year archive

STARPHARMA HOLDINGS LIMITED — 2006 filings

All 46 regulatory filings released by STARPHARMA HOLDINGS LIMITED (SPL) in 2006, sourced directly from the official regulator.

46 Filings
2006 Period
2006 filings (46)
Filing Released Lang
Change of Director's Interest Notice 2 pages ?Kb
Director's Dealing
2006-12-13 English
Initial Director's Interest Notice 2 pages ?Kb
Director's Dealing
2006-11-30 English
Change of Director's Interest Notice 2 pages ?Kb
Regulatory Filings
2006-11-26 English
Retired Dow Corning Chairman Appointed to Board/ 2 pages ?Kb
Regulatory Filings
2006-11-16 English
Appendix 3B 9 pages ?Kb
Regulatory Filings
2006-11-16 English
Advice of number of shares issued 1 page ?Kb
Regulatory Filings
2006-11-15 English
AGM Chairman's Address and CEO Presentation 36 pages ?Kb
Regulatory Filings
2006-11-14 English
Results of AGM 3 pages ?Kb
Regulatory Filings
2006-11-14 English
VivaGel Market Update 3 pages ?Kb
Regulatory Filings
2006-11-12 English
Commitments Test Entity - First Quarter Report 4 pages ?Kb
Regulatory Filings
2006-10-30 English
Becoming a substantial holder 7 pages ?Kb
Regulatory Filings
2006-10-24 English
US Clinical Trial of VivaGel for Genital Herpes Commences 3 pages ?Kb
Regulatory Filings
2006-10-23 English
Completes acquisition of US based Dendritic Nanotechnologies 2 pages ?Kb
M&A Activity
2006-10-22 English
Appendix 3B 9 pages ?Kb
Capital/Financing Update
2006-10-22 English
Becoming a substantial holder 5 pages ?Kb
Major Shareholding Notification
2006-10-22 English
CEO Presentation to Lux Executive Summit 1 page ?Kb
Investor Presentation
2006-10-16 English
Notice of Annual General Meeting/Proxy Form 9 pages ?Kb
AGM Information
2006-10-12 English
Presenting to Asia Pacific Life Science Forum London 1
Investor Presentation
2006-10-11 English
Ceasing to be a substantial holder 1 page ?Kb
Major Shareholding Notification
2006-10-11 English
Change of Director's Interest Notice 2 pages ?Kb
Director's Dealing
2006-10-10 English
Appendix 3B-Employee share options 9 pages ?Kb
Share Issue/Capital Change
2006-10-10 English
DNT Acquisition Investor Presentation 36 pages ?Kb
Regulatory Filings
2006-10-08 English
To Acquire Dendritic Nanotechnologies Inc 4 pages ?Kb
M&A Activity
2006-10-03 English
Trading Halt 2 pages ?Kb
Regulatory Filings
2006-10-02 English
Investee Company DNT announces NCI Contract 3 pages ?Kb
Regulatory Filings
2006-09-28 English
Annual Report 86 pages ?Kb
Annual Report
2006-09-25 English
Release of securities under voluntary escrow 1 page
Regulatory Filings
2006-09-25 English
Preliminary Final Report 24 pages ?Kb
Regulatory Filings
2006-09-06 English
Update Report to Shareholders September 2006 4 pages ?Kb
Annual Report
2006-09-06 English
Initiates NIH-funded human trial for VivaGel 2 pages ?Kb
Regulatory Filings
2006-08-23 English
Commitments Test Entity - Fourth Quarter Report 5 pages ?Kb
Interim / Quarterly Report
2006-07-27 English
VivaGel IND for Genital Herpes Trial clears US FDA 2 pages ?Kb
Regulatory Filings
2006-07-18 English
Initial Director's Interest Notice 2 pages ?Kb
Director's Dealing
2006-07-05 English
Appoints new Chief Executive Officer 2 pages ?Kb
Regulatory Filings
2006-07-02 English
IND Lodged with FDA for VivaGel Genital Herpes Trial 2 pages ?Kb
Regulatory Filings
2006-06-25 English
Investee Coy DNT Announces Commercial Rollout of Priostar 3 pages ?Kb
Regulatory Filings
2006-06-19 English
VivaGel is a Potent Contraceptive in Animal Model 3 pages ?Kb
Regulatory Filings
2006-06-13 English
Presentation to Australian BioInvestment Forum 35 pages ?Kb
Investor Presentation
2006-06-13 English
Commitments Test Entity - Third Quarter Report 5 pages ?Kb
Interim / Quarterly Report
2006-04-26 English
NIH Funds Clinical Development of VivaGel for Genital Herpes 2 pages ?Kb
Regulatory Filings
2006-04-19 English
Increasing US investment support for Starpharma 2 pages ?Kb
Capital/Financing Update
2006-04-05 English
Half Yearly Report & Half Year Accounts 35 pages ?Kb
Regulatory Filings
2006-03-08 English
Market Update 36 pages ?Kb
Investor Presentation
2006-02-06 English
Commitments Test Entity - Second Quarter Report 5 pages ?Kb
Interim / Quarterly Report
2006-01-30 English
Vivagel receives Fast Track Status from FDA 2 pages ?Kb
Regulatory Filings
2006-01-08 English
Expiry of Options 1 page ?Kb
Share Issue/Capital Change
2006-01-04 English